Garg A, Wheldon CW, Galvin AM, Moore JD, Griner SB, Thompson EL The Development and Psychometric Evaluation of the Mid-adult Human Papillomavirus Vaccine Knowledge Scale in the United States. Sex Transm Dis. 2022 Jun 1;49(6):423-428. doi: 10.1097/OLQ.000
Grace-Leitch L, Shneyderman Y Using the Health Belief Model to Examine the Link between HPV Knowledge and Self-Efficacy for Preventive Behaviors of Male Students at a Two-Year College in New York City. Behav Med. 2016 Jul-Sep;42(3):205-10. doi: 10.1080/0
Guvenc G, Seven M, Akyuz A Health Belief Model Scale for Human Papilloma Virus and its Vaccination: Adaptation and Psychometric Testing. J Pediatr Adolesc Gynecol. 2016 Jun;29(3):252-8. doi: 10.1016/j.jpag.2015.09.007. Epub 2015 Sep 26.
Krawczyk A, Perez S, King L, Vivion M, Dube E, Rosberger Z Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother. 2015;11(2):330-6. doi: 10.4161/21645515.2014.980708.
Li Y, Xu C Human Papillomavirus-Related Cancers. Adv Exp Med Biol. 2017;1018:23-34. doi: 10.1007/978-981-10-5765-6_3.
Ojeaga A, Alema-Mensah E, Rivers D, Azonobi I, Rivers B Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA. J Cancer Educ. 2019 Feb;34(1):66-72. doi: 10.1007/s13187-017-1268-6.
Pelullo CP, Di Giuseppe G, Angelillo IF Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy. PLoS One. 2012;7(8):e42856. doi: 10.1371/journal.pone.0042856. Epub 2012 Aug 8.
Sinshaw MT, Berhe S, Ayele SG Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia. Infect Drug Resist. 2022 Mar 3;15:781-793. doi: 10.2147/I
Songane M, Grossmann V The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value. PLoS One. 2021 Jan 11;16(1):e0244722. doi: 10.1371/journal.pone.0244722. eCollection 2021.
Waller J, Ostini R, Marlow LA, McCaffery K, Zimet G Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013 Jan;56(1):35-40. doi: 10.1016/j.ypmed.2012.10.028. Epub 2012 No
Development and Psychometric Testing of a Questionnaire to Assess HPV Knowledge in Indonesia
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
